Navigating the Full Biocompatibility Workflow to Ensure Product Safety

Upgrading the CRISPR Toolbox - New Strategies Sharpen the CRISPR-Cas9 Scissors Utilizing Visualization and Chromatic Accessibility

The annual Cell & Gene Meeting on the Mesa in San Diego kicked off this week with a packed schedule of sessions and some 40 company presentations that speak to the significant progress in these burgeoning therapeutic fields.

After watching the webinar, participants will understand: which diagnostic tests are recommended for chronic vs. acute CV patients; and the diagnostic capabilities of noninvasive tests.

Multiple challenges exist in bioanalytical assay development, from antibody generation to quality control. A researcher must first decide if an analyte will be measured in all or only certain desired forms, identify the sample types or matrices in which it will be measured, and identify the appropriate sensitivity and specificity required of their assay. The role of the antibody (i.e., capture, detection, or reagent), as well as its required format, must also be identified. Lastly, the generated antibodies must be characterized and validated in terms of supply continuity, robustness, reproducibility, and stability. In this webinar, Dr. Royle addresses these challenges and discusses specific antibody generation using Bio-Rad’s HuCAL technology, format flexibility offered by SpyTag technology, antibody formats for different bioanalytical assays, and quality and performance of Bio-Rad antibody products.